SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Tender Offer

24 Feb 2012 08:37

RNS Number : 0608Y
J.P. Morgan Private Equity Ltd
24 February 2012
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDCOMPLETES TENDER OFFER TO PURCHASE SHARES

* * *

 

GUERNSEY, 24 FEBRUARY 2012

 

J.P. Morgan Private Equity Limited (the "Company") is pleased to announce that it has accepted the following shares tendered to it at the applicable Net Asset Value per share as at 31 December 2011:

·; 10,706,290 of US$ Equity Shares at a price of USD 1.27 per share1.

o As discussed in the Company's Circular dated 17 November 2011, the total US$ Equity Shares available for tender was 10,706,336 or 3.0% of the 356,877,850 US$ Equity Shares in issue (excluding treasury) at the time that the tender authority was granted.

The 10,706,336 US$ Equity Shares available for tender represents 2.6658772% of the 401,606,496 US$ Equity Shares in issue (excluding treasury) as of the date of the Circular (17 November 2011).

The scaling ratio for US$ Equity shares tendered in excess of the basic entitlement was 0.0033898.

 

·; 153,284 of 2013 Zero Dividend Preference shares at a price of GBP 0.6570 per share.

 

·; 1,514,935 of 2015 Zero Dividend Preference shares at a price of GBP 0.6267 per share.

 

The number of US$ Equity Shares accepted differs from those which were available for tender due to rounding in order to accommodate each shareholder's basic entitlement.

 

The date of the purchase was 21 February 2012. Cheques were despatched / CREST accounts were credited on 24 February 2012 in respect of the shares tendered. All payments were made in the respective base currencies of each share class.

The shares tendered are held as treasury shares. As a result of this tender offer, the Company holds 25,802,704 US$ Equity Shares, 2,259,803 2013 Zero Dividend Preference Shares and 2,344,176 2015 Zero Dividend preference shares in treasury.

 

Immediately following the tender offer the Company's issued share capital will consist of 386,890,704 shares of no par value (excluding treasury shares) each classified as US$ Equity Shares, 63,159,021 shares of no par value (excluding treasury shares) each classified as 2013 Zero Dividend Preference shares, 67,077,371 shares of no par value (excluding treasury shares) each classified as 2015 Zero Dividend Preference Shares, 30,410,753 shares of no par value (excluding treasury shares) each classified as 2017 Zero Dividend Preference Shares.

Therefore the total number of voting rights in the Company is 386,890,704 for the US$ Equity Share class, 63,159,021 for the 2013 Zero Dividend Preference share class and 67,077,371 for the 2015 Zero Dividend Preference share class. These figures may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FSA's Disclosure and Transparency rules.

 

* * *

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 3032 / +1 212 648 1150

Troy.duncan@jpmorgan.com / Gregory.getschow@jpmorgan.com

 

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPWW, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEAPALADSAEEF
Date   Source Headline
2nd Jun 20269:29 amRNSNet Asset Value - March 2026
23rd Apr 20267:00 amRNSJoint Broker Appointment
14th Apr 20267:00 amRNSAppointment of Directors
6th Mar 20265:59 pmRNSHalf-year Financial Report - December 2025
14th Jan 20269:53 amRNSCOMPLETION OF THIRTEENTH MANDATORY REDEMPTION
29th Dec 20253:18 pmRNSTHIRTEENTH MANDATORY REDEMPTION
19th Dec 20255:53 pmRNSNet Asset Value September 2025
2nd Dec 20254:44 pmRNS2025 AGM Results Statement
10th Nov 202512:19 pmRNS2025 AGM Circular Statement
5th Nov 20254:07 pmRNSHolding(s) in Company
3rd Nov 20254:30 pmRNSHolding(s) in Company
3rd Nov 20254:11 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNSAnnual Financial Report 2025
22nd Jul 20257:00 amRNSAppointed Sole Corp. Broker & Financial Adviser
10th Jun 20254:47 pmRNSNet Asset Value - March 2025
1st May 20256:11 pmRNSHolding(s) in Company
18th Mar 20255:04 pmRNSHalf-year Report - December 2024
3rd Dec 20242:30 pmRNSNet Asset Value September 2024
27th Nov 20245:16 pmRNS2024 AGM Results
6th Nov 20247:00 amRNS2024 AGM Circular
25th Oct 20247:00 amRNSPortfolio Update
25th Oct 20247:00 amRNSAnnual Financial Report - 2024
5th Jun 20247:00 amRNSNet Asset Value - March 2024
23rd Apr 20245:18 pmRNSDirector Declaration
15th Mar 20246:15 pmRNSNet Asset Value - December 2023
15th Mar 20246:03 pmRNSHalf-year Report - December 2023
15th Mar 20243:50 pmRNSHalf-year Report - 2023
6th Dec 20235:36 pmRNSDirector Declaration
6th Dec 20235:33 pmRNSAGM RESULTS 2023
9th Nov 202311:56 amRNS2023 AGM CIRCULAR
8th Nov 20237:00 amRNSCompletion of Twelfth Mandatory Redemption
24th Oct 20237:00 amRNSTwelfth Mandatory Redemption & Shareholder Update
20th Oct 202310:28 amRNSNet Asset Value - September 2023
21st Sep 20235:33 pmRNSNet Asset Value(s) - June 2023
21st Jun 20233:36 pmRNSDirectorate Change
12th May 20231:46 pmRNSNet Asset Value(s) - March 2023
28th Mar 20233:32 pmRNSHalf-year Report - 31 December 2022
14th Mar 20234:35 pmRNSPrice Monitoring Extension
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 202311:05 amRNSSecond Price Monitoring Extn
14th Mar 202311:00 amRNSPrice Monitoring Extension
14th Mar 20239:05 amRNSSecond Price Monitoring Extn
14th Mar 20239:00 amRNSPrice Monitoring Extension
24th Feb 20234:22 pmRNSNet Asset Value(s) - December 2022
13th Feb 20234:51 pmRNSDirector Declaration
22nd Dec 20227:00 amRNSCompletion of Eleventh Mandatory Redemption
14th Dec 20227:00 amRNSELEVENTH MANDATORY REDEMPTION & SHAREHOLDER UPDATE
13th Dec 20225:09 pmRNSDirectorate Change
29th Nov 20224:33 pmRNSAGM Results 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.